全球化学品在线数据库
| CAS 登录号 | 产品名称 | 分子式 |
|---|---|---|
| 281235-04-9 | Methyl 4-(piperidin-4-yl)benzoate;4-Piperidin-4-ylbenzoic acid methyl ester | C13H17NO2 |
| 281652-58-2 | 5-Iodo-2-chlorobenzoyl chloride;2-Chloro-5-iodobenzoyl chloride | C7H3Cl2IO |
| 281655-37-6 | (3S)-3,4-Morpholinedicarboxylic acid 4-(9H-fluoren-9-ylmethyl) ester | C20H19NO5 |
| 282089-49-0 | N-(1,3-Benzodioxol-5-ylmethyl)-1,2-dihydro-7-methoxy-2-oxo-8-(pentyloxy)-3-quinolinecarboxamide;JTE 907 | C24H26N2O6 |
| 282109-83-5 | 1,3-Bis(2,6-diisopropylphenyl)-4,5-dihydroimidazolium tetrafluoroborate | C27H39N2.BF4 |
| 282116-97-6 | [4-(2-Ethoxy-2-oxoethoxy)phenyl]boronic acid | C10H13BO5 |
| 282524-82-7 | 3-Amino-3-(4-tert-butylphenyl)propanoic acid | C13H19NO2 |
| 282524-86-1 | Boc-3-amino-3-(4'-bromophenyl)propionic acid;3-(4-Bromophenyl)-3-[(tert-butoxycarbonyl)amino]propanoic acid | C14H18BrNO4 |
| 282526-98-1 | Cetilistat;2-(Hexadecyloxy)-6-methyl-4H-3,1-benzoxazin-4-one | C25H39NO3 |
| 282734-63-8 | 1-Benzenesulfonyl-2-iodo-7-azaindole | C13H9IN2O2S |
| 282735-66-4 | (5R,6S)-5,6-Diphenyl-2-morpholinone | C16H15NO2 |
| 283158-18-9 | 8-Hydroxy-5-quinolinesulfonic acid monohydrate | C9H7NO4S.H2O |
| 283159-90-0 | Valiphenal;IR 5885; Valifenalate; N-[(1-Methylethoxy)carbonyl]-L-valyl-3-(4-chlorophenyl)-beta-alanine methyl ester | C19H27ClN2O5 |
| 283159-95-5 | (S)-Methyl 3-amino-3-(4-chlorophenyl)propanoate | C10H12ClNO2 |
| 283160-20-3 | (3S)-3-(9H-Fluoren-9-ylmethoxycarbonylamino)-5-oxo-5-[tri(phenyl)methylamino]pentanoic acid;Fmoc-beta-Homoasn(Trt)-OH | C39H34N2O5 |
| 283167-28-2 | (1-Acetyl-4-piperidinyl)carbamic acid 1,1-dimethylethyl ester | C12H22N2O3 |
| 283173-50-2 | 8-Fluoro-1,3,4,5-tetrahydro-2-[4-[(methylamino)methyl]phenyl]-6H-pyrrolo[4,3,2-ef][2]benzazepin-6-one;8-Fluoro-2-[4-[(methylamino)methyl]phenyl]-1,3,4,5-tetrahydro-6H-azepino[5,4,3-cd]indol-6-one | C19H18FN3O |
| 283173-80-8 | 2-Bromo-8-fluoro-1,3,4,5-tetrahydro-6H-azepino[5,4,3-cd]indol-6-one | C11H8BrFN2O |
| 283173-84-2 | 4-(8-Fluoro-3,4,5,6-tetrahydro-6-oxo-1H-azepino[5,4,3-cd]indol-2-yl)benzaldehyde | C18H13FN2O2 |
| 284027-36-7 | 8-Trifluoromethyl-1,2,3,4-tetrahydroisoquinoline;1,2,3,4-Tetrahydro-8-(trifluoromethyl)isoquinoline | C10H10F3N |
| 284028-89-3 | XAV 939;3,5,7,8-Tetrahydro-2-[4-(trifluoromethyl)phenyl]-4H-thiopyrano[4,3-d]pyrimidin-4-one | C14H11F3N2OS |
| 284028-90-6 | DR 2313;SC-202756; 3,5,7,8-Tetrahydro-2-methyl-4H-thiopyrano[4,3-d]pyrimidin-4-one | C8H10N2OS |
| 284030-57-5 | 4-Amino-2,3-difluoro-5-nitrobenzoic acid | C7H4F2N2O4 |
| 284030-58-6 | Methyl 4-amino-2,3-difluoro-5-nitrobenzoate | C8H6F2N2O4 |
| 284035-33-2 | NPS 2143;2-Chloro-6-[(2R)-3-[[1,1-dimethyl-2-(2-naphthalenyl)ethyl]amino]-2-hydroxypropoxy]benzonitrile | C24H25ClN2O2 |
| 284049-75-8 | 3-Butyl-1-methylimidazolium acetate;Basionics BC 02; [Bmin][OOCCH3] | C8H15N2.C2H3O2 |
| 284461-73-0 | Sorafenib;4-[4-[[4-Chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methyl-pyridine-2-carboxamide | C21H16ClF3N4O3 |
| 284461-74-1 | N-Desmethyl Sorafenib;C1=CC(=CC=C1NC(=O)NC2=CC(=C(C=C2)Cl)C(F)(F)F)OC3=CC(=NC=C3)C(=O)N | C20H14ClF3N4O3 |
| 284462-37-9 | 4-(4-Aminophenoxy)-N-methylpicolinamide | C13H13N3O2 |
| 284463-96-3 | 3,4,5-Trifluorotoluene | C7H5F3 |
| 284472-79-3 | 1-(11bS)-Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-yl-piperidine;(S)-PipPhos | C25H22NO2P |
| 284477-00-5 | 2-Quinolineacetic acid | C11H9NO2 |
| 284493-53-4 | 3-N-Boc-amino-3-(3-methoxyphenyl)propionic acid | C15H21NO5 |
| 284493-56-7 | 3-N-Boc-amino-3-(2-fluorophenyl)propionic acid | C14H18FNO4 |
| 284493-58-9 | Boc-3-amino-3-(3'-bromophenyl)propionic acid;3-(3-Bromophenyl)-3-[(tert-butoxycarbonyl)amino]propanoic acid | C14H18BrNO4 |
| 284493-59-0 | 3-N-Boc-amino-3-(3-fluorophenyl)propionic acid | C14H18FNO4 |
| 284493-65-8 | Boc-3-amino-3-(4'-chlorophenyl)propionic acid;4-Chloro-beta-[[(tert-butoxy)carbonyl]amino]benzenepropanoic acid | C14H18ClNO4 |
| 284493-66-9 | Boc-3-amino-3-(2'-chlorophenyl)propionic acid;3-[(tert-Butoxycarbonyl)amino]-3-(2-chlorophenyl)propanoic acid | C14H18ClNO4 |
| 284493-67-0 | 3-Boc-amino-3-(3'-chlorophenyl)propioinic acid;3-[(tert-Butoxycarbonyl)amino]-3-(3-chlorophenyl)propanoic acid; tert-Butyl [3-bromo-1-(3-chlorophenyl)propyl]carbamate | C14H18ClNO4 |
| 284493-72-7 | 3-(Boc-amino)-3-(4-fluorophenyl)propionic acid | C14H18FNO4 |
| 284679-97-6 | 3-Nitro-4-(1-pyrrolidino)benzaldehyde;3-Nitro-4-(1-pyrrolidinyl)benzaldehyde | C11H12N2O3 |
| 285135-89-9 | (3E)-4-Ethoxy-1,1-difluoro-3-buten-2-one | C6H8F2O2 |
| 285570-60-7 | Caspase-3 Inhibitor III;N-Acetyl-L-alpha-aspartyl-L-alpha-glutamyl-N-[(1S)-1-(carboxymethyl)-3-chloro-2-oxopropyl]-L-valinamide; Ac-DEVD-CMK | C21H31ClN4O11 |
| 285978-18-9 | Uridine-<sup>13</sup>C<sub>9</sub>-<sup>15</sup>N<sub>2</sub> 5'-(tetrahydrogen triphosphate) sodium salt | C9H15N2O15P3.x(Na) |
| 285978-24-7 | N-(Phosphonomethyl)glycine-2-<sup>13</sup>C-<sup>15</sup>N | C3H8NO5P |
| 285983-48-4 | Doramapimod;1-(3-(1,1-Dimethylethyl)-1-(4-methylphenyl)-1H-pyrazol-5-yl)-3-(4-(2-(morpholin-4-yl)ethoxy)naphthalen-1-yl)urea; 1-[2-(4-Methylphenyl)-5-tert-butyl-pyrazol-3-yl]-3-[4-(2-morpholin-4-ylethoxy)naphthalen-1-yl]urea | C31H37N5O3 |
| 285984-25-0 | 5-tert-Butyl-2-p-tolyl-2H-pyrazol-3-ylamine | C14H19N3 |
| 285986-88-1 | N-[2-[(4-Chlorophenyl)amino]-1-methyl-2-oxoethoxy]-3,5-bis(trifluoromethyl)benzamide;CCG 1423 | C18H13ClF6N2O3 |
| 285991-64-2 | 4-Chlorofuro[3,4-c]pyridin-3(1H)-one | C7H4ClNO2 |
| 286014-25-3 | 1,3-Bis(2,6-diisopropylphenyl)imidazolium tetrafluoroborate;N,N'-Bis(2,6-diisopropylphenyl)imidazoliumtetrafluoroborate | C27H37N2.BF4 |